ARDELYX, INC. Restructuring Reserve, Current
ARDELYX, INC. (ARDX) had Restructuring Reserve, Current of $0 as of 2022-12-31, per its 10-K filed 2023-03-02.
Discontinued › Notes
us-gaap:RestructuringReserveCurrent · last filed 2023-03-02
- 2022-12-31: Restructuring Reserve, Current $0.00.
- 2021-12-31: Restructuring Reserve, Current $500.00K.
| Period end | Restructuring Reserve, Current |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-02 |
| 2021-12-31 | $500.00K 10-K · filed 2023-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |